Oxygenator thrombosis: An international phenomenon

Perfusion

Volumn 14, Issue 6, 1999, Pages 425-435

  Schaadt, Jennifer ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; HEPARIN;

ARTICLE; CARDIOPULMONARY BYPASS; DISEASE PREDISPOSITION; GAS DIFFUSION; HUMAN; HYPERCOAGULABILITY; OXYGENATOR; PRIORITY JOURNAL; SHUNTING; THROMBOSIS;

EID: 0032744911     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919901400605     Document Type: Article

References (37)

1. Jansson E. Casualty due to fibrin discharge in oxygenators. Scanmag 1990; 3: 13-14.
2. Kronlund P, Aberg B, Blömback M. Coagulation formation in membrane oxygenators. Scanmag 1992; 1: 18-19.
3. Blömback M, Kronlund P, Aberg B et al. Pathologic fibrin formation and cold induced clotting of membrane oxygenators during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1995; 9: 34-43.
4. Williams S, Fatah K, Ivert T, Blömback M. The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator. Blood Coagul Fibrinolysis 1995; 6: 718-25.
5. Bearrs MG, Ericson D, Parks PJ, Rice R. The puzzling case of cryoprecipitation. AmSECT Today 1996; June: 24-25.
6. Trocchio CR. Hemodynamic changes in membrane oxygenators. Presented at Cardiopulmonary bypass in the 90s - VII, Atlanta, GA, USA, 1998.
7. Palanzo DA, Manly NJ, Montesano RM et al. Potential problems when using the new lower prime hollow fiber membrane oxygenators with uncoated stainless steel heat exchangers. Perfusion 1996; 11: 481-85.
8. Palanzo DA, Zarro DL, Montesano RM, Quinn M, Gustafson PA. Effect of surface coating on platelet drop during cardiopulmonary bypass. Perfusion 1999; 14: 197-200.
9. Adrian K, Mellgren K, Skoby M et al. The effect of albumin priming solutions on platelet activation during experimental long term perfusion. Perfusion 1998; 13: 187-91.
10. Myers GJ. A comparative review of crystalloid, albumin, pentastarch and hetastarch as perfusates for cardiopulmonary bypass. J Extracorp Technol 1997; 29: 30-35.
11. Wahba A, Philipp A, Behr R, Birnbaum DE. Heparin coated equipment reduces the risk of oxygenator failure. Ann Thorac Surg 1998; 65: 1310-12.
12. Schmidt B, Kind K, Knobl HJ, Korfer R. Experience with the AOThel coated affinity oxygenators with regard to the delta P problem. Presented at the 27th International Congress of the German Kardiotechnicians, Fulda, Germany, 1998.
13. Boldt J, Zickmann B, Ballesteros BM, Stertmann F, Hempelmann S. Influence of five different priming solutions on platelets function in patients undergoing cardiac surgery. Anesth Analg 1992; 74: 219-25.
14. Faraday N, Rosenfeld BA, Herfel BM. Hypothermia increases intrinsic platelets reactivity in vitro. Anesth Analg 1995; 80: SCA1-141.
15. Schaadt J. Fiber manufacturing, membrane classification and winding technologies associated with membrane oxygenators. J Extracorp Technol 1998; 30: 30-34.
16. Williams WJ. Hematology in the aged. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ eds. Williams' hematology, 5th edition. New York: McGraw-Hill, 1995: 72-77.
17. Cannon C. The pharmacology of anticoagulation. In: Pifarre R ed. Anticoagulation, hemostasis, and blood preservation in cardiovascular surgery. Philadelphia, PA: Hanley & Belfus, 1993: 1-22.
18. Horrow J. Management of coagulapathy associated with CPB. In: Gravlee GP, Davis RF, Utley JR eds. Cardiopulmonary bypass principles and practice. Baltimore, MD: Williams & Wilkins, 1993: 436-66.
19. Bauer KA, Rosenberg RD. Control of coagulation reactions. In: Beutler E, Lichtman MA, Coller BS, Kipp TJ eds. Williams' hematology, 5th edition. New York: McGraw-Hill, 1995: 1239-52.
20. Bauer KA. The hypercoagulable state. In: Beutler E, Lichtman MA, Coller BS, Kipp TJ eds. Williams' hematology, 5th edition. New York: McGraw-Hill, 1995: 1531-50.
21. Gralnick HR, Connaghan DG. Hereditary abnormalities of fibrinogen. In: Beutler E, Lichtman MA, Coller BS, Kipp TJ eds. Williams' hematology, 5th edition. New York: McGraw-Hill, 1995: 1439-54.
22. Hamsten A, Iselius L, Faire U, Blömback M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987; 2: 988-91.
23. Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 1: 1050-54.
24. Meade TW, Duddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity clotting factors and long-term incidence of ischaemic heart disease in the Northwick Park heart study. Lancet 1993; 342: 1076-79.
25. Szefner J, Cabrol C. Control and treatment of hemostasis in patients with a total artificial heart: the experience of the La Pitie. In: Pifarre R ed. Anticoagulation, hemostasis and blood preservation in cardiovascular surgery. Philadelphia, PA: Hanley & Belfus, 1993: 237-64.
26. Taylor KM. Effect of aprotinin on blood loss and blood use after cardiopulmonary bypass. In: Pifarre R ed. Anticoagulation, hemostasis and blood preservation in cardiovascular surgery. Philadelphia, PA: Hanley & Belfus, 1993: 129-45.
27. Berkowitz SD, Ruggeri ZM, Zimmerman TS. Von Willebrand disease. In: Coagulation and bleeding disorders. New York: Marcel Dekker, 1989: 215-59.
28. Storkmorken H, Erikssen J. Plasma antithrombin III and factor VIII antigen in relation to angiographic findings, angina and blood groups in middle age men. Thromb Haemost 1977; 38: 874-80.
29. Frohlich M, Sund M, Russ S et al. Seasonal variations of rheological and hemostatic parameters and acute phase reactants in young healthy subjects. Arterioscler Thromb Vasc Biol 1997; 17: 2692-97.
30. van der Bom JG, de Matt MP, Bots ML, Hofman A, Kluft C, Grobbee DE. Seasonal variation on fibrinogen in the Rotterdam study. Thromb Haemost 1997; 78: 1059-62.
31. Wahlberg TB, Savidge GF, Blömback M, Wiechel B. Influence of age, sex and blood groups on 15 blood coagulation variables in a reference material composed of 80 blood donors. Vox Sang 1990; 39: 301-308.
32. Smith SB, Arkin C. Cryofibrinogenemia: incidence, clinical correlation and a review of the literature. Am J Clin Pathol 1972; 58: 524-30.
33. Gorevic PD. Cryopathies: cryoglobins and cryofibrinogenemia. In: Frank MM, Austen KF, Claman HN, Unanue ER eds. Samter's immunologic diseases, 5th edition. Baltimore, MD: Little, Brown, 1995: 951-72.
34. Agarwal SK, Ghosh PK, Gupta D. Cardiac surgery and cold-reactive proteins. Ann Thorac Surg 1995; 60: 1143-50.
35. Beightler E, Diven DG, Sanchez RL, Salomon AR. Thrombotic vasculopathies associated with cryofibrinogenemia. J Am Acad Dermatol 1991; 24: 342-45.
36. Stathakis NE, Masesson MN, Chen AB, Galanakis DK. Ciyoprecipitation of fibrin-fibrinogen complexes induced by the cold insoluable globulin of plasma. Blood 1978; 51: 1211-22.
37. McKee PA, Kalbfleisch JM, Bird RM. Incidence and significance of cryofibrinogenemia. J Lab Clin Med 1962; 61: 203-10.